Boston Scientific says cyberattack likely to affect 2026 results
Published on 10/06/2026 at 20:00 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Boston Scientific said in a September 8, 2026 filing with the U.S. Securities and Exchange Commission that a cybersecurity incident identified on August 25 had disrupted global operations. The company said the incident affected certain information technology systems and its ability to manufacture, process and ship customer orders.
Operational recovery remains in progress
Boston Scientific reported substantial restoration of its distribution network, with major distribution centers processing and shipping orders at or above normal operating levels. The company also said sterilization facilities were operational and manufacturing had resumed across most facilities globally, while the timeline for full recovery remained uncertain. The SEC filing said Boston Scientific had not identified evidence of ongoing unauthorized access at that time.
Impact on 2026 guidance
Boston Scientific said the incident was likely to have a material impact on its results for the third quarter and full year of 2026. The company said it was unlikely to meet the net sales growth and adjusted earnings-per-share guidance ranges it had provided on July 29, 2026. It expected to recover some affected revenue as operations ramped up and backlogs were reduced, but said the full impact was not yet known. Boston Scientific planned to provide an operational and financial outlook update during its third-quarter 2026 results call on October 28, 2026. The filing said the company did not expect the incident to have a material impact on its long-term financial condition.
